Human Health Holdings Limited

SEHK:1419 Stock Report

Market Cap: HK$315.0m

Human Health Holdings Management

Management criteria checks 2/4

Human Health Holdings' CEO is Kin Ping Chan, appointed in Jun 2015, has a tenure of 10.5 years. total yearly compensation is HK$5.45M, comprised of 85% salary and 15% bonuses, including company stock and options. directly owns 1.8% of the company’s shares, worth HK$5.69M. The average tenure of the management team and the board of directors is 10.4 years and 10.5 years respectively.

Key information

Kin Ping Chan

Chief executive officer

HK$5.4m

Total compensation

CEO salary percentage85.02%
CEO tenure10.5yrs
CEO ownership1.8%
Management average tenure10.4yrs
Board average tenure10.5yrs

Recent management updates

Human Health Holdings Limited's (HKG:1419) CEO Might Not Expect Shareholders To Be So Generous This Year

Dec 03
Human Health Holdings Limited's (HKG:1419) CEO Might Not Expect Shareholders To Be So Generous This Year

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25
We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Recent updates

Human Health Holdings' (HKG:1419) Dividend Will Be Increased To HK$0.03

Dec 08
Human Health Holdings' (HKG:1419) Dividend Will Be Increased To HK$0.03

Human Health Holdings Limited's (HKG:1419) CEO Might Not Expect Shareholders To Be So Generous This Year

Dec 03
Human Health Holdings Limited's (HKG:1419) CEO Might Not Expect Shareholders To Be So Generous This Year

We Think Human Health Holdings' (HKG:1419) Healthy Earnings Might Be Conservative

Nov 06
We Think Human Health Holdings' (HKG:1419) Healthy Earnings Might Be Conservative

Human Health Holdings (HKG:1419) Is Increasing Its Dividend To HK$0.03

Oct 28
Human Health Holdings (HKG:1419) Is Increasing Its Dividend To HK$0.03

Human Health Holdings (HKG:1419) Has Announced That It Will Be Increasing Its Dividend To HK$0.03

Sep 29
Human Health Holdings (HKG:1419) Has Announced That It Will Be Increasing Its Dividend To HK$0.03

These 4 Measures Indicate That Human Health Holdings (HKG:1419) Is Using Debt Safely

Sep 26
These 4 Measures Indicate That Human Health Holdings (HKG:1419) Is Using Debt Safely

Human Health Holdings Limited (HKG:1419) May Have Run Too Fast Too Soon With Recent 30% Price Plummet

Sep 26
Human Health Holdings Limited (HKG:1419) May Have Run Too Fast Too Soon With Recent 30% Price Plummet

Revenues Not Telling The Story For Human Health Holdings Limited (HKG:1419) After Shares Rise 35%

Aug 12
Revenues Not Telling The Story For Human Health Holdings Limited (HKG:1419) After Shares Rise 35%

Human Health Holdings (HKG:1419) Will Want To Turn Around Its Return Trends

Jul 23
Human Health Holdings (HKG:1419) Will Want To Turn Around Its Return Trends

Why Human Health Holdings' (HKG:1419) Earnings Are Better Than They Seem

Apr 01
Why Human Health Holdings' (HKG:1419) Earnings Are Better Than They Seem

Human Health Holdings (HKG:1419) Will Be Hoping To Turn Its Returns On Capital Around

Mar 19
Human Health Holdings (HKG:1419) Will Be Hoping To Turn Its Returns On Capital Around

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25
We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13
Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23
Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21
Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26
Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

May 31
Is Human Health Holdings (HKG:1419) Using Too Much Debt?

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Feb 15
Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Dec 25
Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

CEO Compensation Analysis

How has Kin Ping Chan's remuneration changed compared to Human Health Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025HK$5mHK$5m

HK$26m

Mar 31 2025n/an/a

HK$24m

Dec 31 2024n/an/a

HK$21m

Sep 30 2024n/an/a

HK$23m

Jun 30 2024HK$4mHK$3m

HK$24m

Mar 31 2024n/an/a

-HK$22m

Dec 31 2023n/an/a

-HK$67m

Sep 30 2023n/an/a

HK$57m

Jun 30 2023HK$5mHK$2m

HK$181m

Mar 31 2023n/an/a

HK$367m

Dec 31 2022n/an/a

HK$553m

Sep 30 2022n/an/a

HK$464m

Jun 30 2022HK$3mHK$2m

HK$375m

Mar 31 2022n/an/a

HK$297m

Dec 31 2021n/an/a

HK$218m

Sep 30 2021n/an/a

HK$181m

Jun 30 2021HK$2mHK$2m

HK$144m

Mar 31 2021n/an/a

HK$59m

Dec 31 2020n/an/a

-HK$27m

Sep 30 2020n/an/a

-HK$33m

Jun 30 2020HK$2mHK$2m

-HK$40m

Mar 31 2020n/an/a

-HK$11m

Dec 31 2019n/an/a

HK$19m

Sep 30 2019n/an/a

HK$23m

Jun 30 2019HK$2mHK$2m

HK$27m

Compensation vs Market: Kin Ping's total compensation ($USD700.12K) is above average for companies of similar size in the Hong Kong market ($USD234.15K).

Compensation vs Earnings: Kin Ping's compensation has increased by more than 20% in the past year.


CEO

Kin Ping Chan (61 yo)

10.5yrs
Tenure
HK$5,448,000
Compensation

Mr. Kin Ping Chan, BBS, J.P, serves as the Chairman of the Board at Human Health Holdings Limited and has been its Chief Executive Officer and Executive Director since June 9, 2015. Mr. Chan is a Co-Owner...


Leadership Team

NamePositionTenureCompensationOwnership
Kin Ping Chan
Chairman of the Board & CEO10.5yrsHK$5.45m1.8%
HK$ 5.7m
Chun Pong Poon
COO & Executive Director12.3yrsHK$3.12m0.13%
HK$ 403.4k
Lai Sheung Pang
Chief Medical Officer & Executive Directorno dataHK$5.45mno data
Tin Wai Chan
Group CFO2.8yrsno datano data
Siu Keung Seto
Co-Head of Dental Unit10.4yrsno datano data
Wai Man Lau
Co-Head of Dental Unit10.4yrsno datano data
Ching Yan Man
Company Secretary8.5yrsno datano data
10.4yrs
Average Tenure
59yo
Average Age

Experienced Management: 1419's management team is seasoned and experienced (10.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kin Ping Chan
Chairman of the Board & CEO10.5yrsHK$5.45m1.8%
HK$ 5.7m
Chun Pong Poon
COO & Executive Director10.5yrsHK$3.12m0.13%
HK$ 403.4k
Lai Sheung Pang
Chief Medical Officer & Executive Director10.5yrsHK$5.45mno data
Yue Kwong Chan
Independent Non-Executive Director9.9yrsHK$180.00kno data
Sun Wing Lui
Independent Non-Executive Director9.9yrsHK$180.00kno data
Kin Hung Kwong
Member of Doctor Advisory Board16.3yrsno datano data
Huen Lee
Member of Doctor Advisory Board13.2yrsno datano data
Hey Man Chan
Independent Non-Executive Director1.2yrsHK$135.00kno data
10.5yrs
Average Tenure
55yo
Average Age

Experienced Board: 1419's board of directors are seasoned and experienced ( 10.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/10 23:49
End of Day Share Price 2025/12/10 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Human Health Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.